Taboola to Present in Upcoming Investor Conferences

NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in powering recommendations for the open web, today announced that members of its management team will participate in the following investor conferences:

Event: Oppenheimer 9th Annual Emerging Growth Conference
Date: Thursday, May 9, 2024

Event: 19th Annual Needham Technology, Media, & Consumer Conference
Date: Wednesday, May 15, 2024
Presentation Time: 1:30 p.m. ET

Event: J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference
Date: Tuesday, May 21, 2024
Presentation Time: 10:10 a.m. ET

Event: B. Riley Securities 2024 Institutional Investor Conference
Date: Wednesday, May 22, 2024

Event: Annual Oppenheimer Israeli Conference
Date: Wednesday, May 29, 2024

Event: TD Cowen 52nd Annual Technology, Media & Telecom Conference
Date: Thursday, May 30, 2024
Presentation Time: 9:40 a.m. ET

A live webcast and replay of the fireside chats will be available on Taboola’s investor relations website at www.taboola.com/about/investors.

About Taboola

Taboola powers recommendations for the open web, helping people discover things they may like. The company’s platform, powered by artificial intelligence, is used by digital properties, including websites, devices and mobile apps, to drive monetization and user engagement. Taboola has long-term partnerships with some of the top digital properties in the world, including Yahoo, CNBC, BBC, NBC News, Business Insider, The Independent and El Mundo. Around 18,000 advertisers use Taboola to reach nearly 600 million daily active users in a brand-safe environment. Taboola is a leader in powering e-commerce recommendations, driving more than 1 million monthly transactions, with leading brands including Walmart, Macy’s, Skechers and eBay among key customers.

Learn more at www.taboola.com and follow @taboola on Twitter.

Investor Contact:
Jessica Kourakos
[email protected]

Press contact:
Dave Struzzi
[email protected]

You May Also Be Interested In

• Form 8.3 - [GOOCH & HOUSEGO PLC - 16 07 2026 - OPENING DISCLOSURE] - (CGWL)
• Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline
• LIFT Announces Commencement of Drilling at the Adina-Galinée Lithium Project, Québec